These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 12628670
21. Studies on the synthesis of some xanthonoid derivatives possessing antiplatelet effects. Lin CN, Fang SC, Lin HC, Ko FN, Shieh BJ, Liu HW, Teng CM. J Pharm Pharmacol; 1994 Nov; 46(11):917-21. PubMed ID: 7897599 [Abstract] [Full Text] [Related]
22. Cloricromene inhibits the activation of human platelets by ADP alone or in combination with adrenaline. Del Maschio A, Bazzoni G, Zatta A, Chen ZM, Dejana E, Prosdocimi M. Eur J Pharmacol; 1990 Oct 23; 187(3):541-5. PubMed ID: 2073928 [Abstract] [Full Text] [Related]
23. New pyrazolylhydrazone derivatives as inhibitors of platelet aggregation. da Silveira IA, Paulo LG, de Miranda AL, Rocha SO, Freitas AC, Barreiro EJ. J Pharm Pharmacol; 1993 Jul 23; 45(7):646-9. PubMed ID: 8105062 [Abstract] [Full Text] [Related]
24. Platelet antiaggregant methoxyphenylthienyl ketoxime ethers: synthesis and structure-activity relationships. Varache-Lembège M, Nuhrich A, Renard P, Duboudin F, Vercauteren J, Devaux G. Arch Pharm (Weinheim); 1995 May 23; 328(5):417-24. PubMed ID: 7611837 [Abstract] [Full Text] [Related]
25. Novel non-peptide GPIIb/IIIa antagonists: synthesis and biological activities of 2-[4-[2-(4-amidinobenzoylamino)-2-(substituted)acetyl]-3-(2-methoxy-2-oxoethyl)-2-oxopiperazinyl] acetic acids. Kitamura S, Fukushi H, Miyawaki T, Kawamura M, Terashita Z, Sugihara H, Naka T. Chem Pharm Bull (Tokyo); 2001 Mar 23; 49(3):258-67. PubMed ID: 11253914 [Abstract] [Full Text] [Related]
26. Inhibition of human leukocyte elastase. 2. Inhibition by substituted cephalosporin esters and amides. Finke PE, Ashe BM, Knight WB, Maycock AL, Navia MA, Shah SK, Thompson KR, Underwood DJ, Weston H, Zimmerman M. J Med Chem; 1990 Sep 23; 33(9):2522-8. PubMed ID: 2391692 [Abstract] [Full Text] [Related]
28. Synthesis and in vitro inhibitory activity on human platelet aggregation of novel properly substituted 4-(1-piperazinyl)coumarins. Di Braccio M, Grossi G, Roma G, Grazia Signorello M, Leoncini G. Eur J Med Chem; 2004 May 18; 39(5):397-409. PubMed ID: 15110966 [Abstract] [Full Text] [Related]
30. Pyran derivatives XIX. (Dialkylamino) substituted 1-benzopyranones and naphthopyranones with platelet antiaggregating activity. Di Braccio M, Roma G, Leoncini G, Poggi M. Farmaco; 1995 Oct 26; 50(10):703-11. PubMed ID: 8590578 [Abstract] [Full Text] [Related]
31. Synthesis of N6-alkyl(aryl)-2-alkyl(aryl)thioadenosines as antiplatelet agents. Liu G, Xu J, Chen N, Zhang S, Ding Z, Du H. Eur J Med Chem; 2012 Jul 26; 53():114-23. PubMed ID: 22531380 [Abstract] [Full Text] [Related]
32. Synthesis of novel indole hydrazone derivatives and evaluation of their antiplatelet aggregation activity. Mashayekhi V, Haj Mohammad Ebrahim Tehrani K, Amidi S, Kobarfard F. Chem Pharm Bull (Tokyo); 2013 Jul 26; 61(2):144-50. PubMed ID: 23154304 [Abstract] [Full Text] [Related]
33. Relationships between chemical structure and inhibition of epinephrine-induced human blood platelet aggregation. Petrusewicz J, Lasslo A, Carter-Burks G, Gollamudi R, Dillingham EO, Bond SE. Biochim Biophys Acta; 1989 Aug 07; 983(2):161-6. PubMed ID: 2758055 [Abstract] [Full Text] [Related]
34. Synthesis and cytotoxic activity of substituted 2-phenyl-3-hydroxy-4(1H)-quinolinones-7-carboxylic acids and their phenacyl esters. Soural M, Hlavác J, Hradil P, Frysová I, Hajdúch M, Bertolasi V, Malon M. Eur J Med Chem; 2006 Apr 07; 41(4):467-74. PubMed ID: 16540209 [Abstract] [Full Text] [Related]
35. Synthesis of 2H-benzo[b][1,4]oxazin-3(4H)-one derivatives as platelet aggregation inhibitors. Tian X, Wang LY, Xia S, Li ZB, Liu XH, Yuan Y, Fang L, Zuo H. Bioorg Med Chem Lett; 2012 Jan 01; 22(1):204-6. PubMed ID: 22137848 [Abstract] [Full Text] [Related]
36. Synthesis and the Evaluations in vitro Antiplatelet Aggregation Activities of 4-Ethoxyisophthalamides. Liu XJ, Shi TE, Wang X, Wei TT, Meng X. Cardiovasc Hematol Agents Med Chem; 2015 Jan 01; 13(2):124-8. PubMed ID: 26695422 [Abstract] [Full Text] [Related]
37. Design, synthesis, and inhibition of platelet aggregation for some 1-o-chlorophenyl-1,2,3,4-tetrahydroisoquinoline derivatives. Yang J, Hua WY, Wang FX, Wang ZY, Wang X. Bioorg Med Chem; 2004 Dec 15; 12(24):6547-57. PubMed ID: 15556771 [Abstract] [Full Text] [Related]
38. New carbamoylpiperidines as human platelet aggregation inhibitors. Guo Z, Zheng X, Thompson W, Dugdale M, Gollamudi R. Bioorg Med Chem; 2000 May 15; 8(5):1041-58. PubMed ID: 10882016 [Abstract] [Full Text] [Related]
39. Effects of aspirin, dipyridamole, nifedipine and cavinton which act on platelet aggregation induced by different aggregating agents alone and in combination. Akopov SE, Gabrielian ES. Eur J Clin Pharmacol; 1992 May 15; 42(3):257-9. PubMed ID: 1577042 [Abstract] [Full Text] [Related]
40. [Design, synthesis, and biological evaluation of phenylpropenamides compounds as anti-platelet aggregation]. Yang Y, Zuo J, Li JM, Ma XD, Zhang YC, Huang WJ. Yao Xue Xue Bao; 2017 Jan 15; 52(1):120-5. PubMed ID: 29911807 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]